Efficacy and safety of long-term phenobarbital therapy of familial cholestasis

C. N. Ghent, J. R. Bloomer, Y. E. Hsia, Paul S. Lietman

Research output: Contribution to journalArticle

Abstract

Two brothers with progressive familial intraheptic cholestasis were followed during four years of phenobarbital therapy to assess its long-term safety and efficacy. Effects attributable to phenobarbital included sustained relief of pruritus, lowering of serum bilirubin levels, and enhanced hepatic excretion of 131I-rose bengal; serum bile acid levels were only transiently decreased. Two brief interruptions in therapy resulted in symptomatic deterioration. Phenobarbital did not retard growth nor impede the response to vitamin D therapy of concomitant rickets.

Original languageEnglish (US)
Pages (from-to)127-132
Number of pages6
JournalJournal of Pediatrics
Volume93
Issue number1
DOIs
Publication statusPublished - 1978
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this